Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

The Lancet

Volumn 345, Issue 8943, 1995, Pages 152-155

  Koster, T ^a   Vandenbroucke, J P ^a   Rosendaal, F R ^a,b   Briet E ^b   Blann, A D ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Hemostasis and Thrombosis Research Centre ^*  (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0028814316     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)90166-3     Document Type: Article

References (26)

1. Epidemiology and pathogenesis of venous thromboembolism
2. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C prediction of a cofactor to activated protein C
3. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
4. Mutation in blood coagulating factor V associated with resistance to activated protein C
5. The effect of ABO blood groups on the diagnosis of von Willebrand disease
6. Bleeding time, blood groups and von Willebrand factor
7. Stabilization of factor VIII in plasma by the von Willebrand factor
8. Relation of ABO blood-groups to atherosclerosis
9. Blood groups, myocardial infarction and angina pectoris among 10,000 adult males
10. ABO blood groups and venous thromboembolic disease
11. Blood group, von Willebrand's factor and heart disease
12. Haemophilia protects against ischaemic heart disease: a study of risk factors
13. Mortality and causes of death in Dutch haemophiliacs 1973-1986
14. Bleeding complications in oral anticoagulant therapy an analysis of risk factors
15. Anticoagulant control and the risk of bleeding; organizational infrastructure
16. Factor VIII related antigen: an improved immunoassay
17. Associations of factor VIII and von Willebrand factor with age, race, sex and risk factors for atherosclerosis
18. Von Willebrand factor, the endothelium and obesity
19. Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human factor VIII/von Willlebrand factor
20. Structures of the asparaginase-linked oligosaccharide chains of human von Willebrand factor
21. Von Willebrand factor endothelial cell damage and atherosclerosis
22. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study
23. Comparative behavior of the components of the factor VIII complex in acute myocardial infarction
24. Inherited predisposition to thrombosis
25. Deficiences of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis
26. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect